| Dr Marshall C Dunaway, | |
|
119 W Hill St, Thomasville, GA 31792-6618 | |
| (229) 225-1900 | |
| (229) 225-3493 |
| Full Name | Dr Marshall C Dunaway |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 60 Years |
| Location | 119 W Hill St, Thomasville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184683377 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 010526 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John D Archbold Memorial Hospital | Thomasville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John D. Archbold Memorial Hospital, Inc. | 4981502622 | 62 |
News Archive
The New York Times examines the growing - and lucrative - practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.
IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
› Verified 2 days ago
| Entity Name | Hospital Authority Of Mitchell County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700830247 PECOS PAC ID: 6002724598 Enrollment ID: O20031117000138 |
News Archive
The New York Times examines the growing - and lucrative - practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.
IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
› Verified 2 days ago
| Entity Name | John D. Archbold Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194779702 PECOS PAC ID: 4981502622 Enrollment ID: O20031219000506 |
News Archive
The New York Times examines the growing - and lucrative - practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.
IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
› Verified 2 days ago
| Entity Name | Grady General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013961507 PECOS PAC ID: 7618866518 Enrollment ID: O20040310001254 |
News Archive
The New York Times examines the growing - and lucrative - practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.
IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
› Verified 2 days ago
| Entity Name | Brooks County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306890942 PECOS PAC ID: 1557279049 Enrollment ID: O20040316000884 |
News Archive
The New York Times examines the growing - and lucrative - practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.
IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
› Verified 2 days ago
| Entity Name | Mcintosh Clinic, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831117746 PECOS PAC ID: 9537157987 Enrollment ID: O20040504000846 |
News Archive
The New York Times examines the growing - and lucrative - practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.
IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marshall C Dunaway, 119 W Hill St, Thomasville, GA 31792-6618 Ph: (229) 225-1900 | Dr Marshall C Dunaway, 119 W Hill St, Thomasville, GA 31792-6618 Ph: (229) 225-1900 |
News Archive
The New York Times examines the growing - and lucrative - practice among doctors to call in colleagues to consult during a surgery or afterward. The need is sometimes questionable, and patients often don't even know the second doctor was involved until the bill arrives.
IT and medical technology company Sectra continues to expand and the number of mammography systems delivered rose 50% during the third quarter compared with the corresponding quarter in 2009/2010. However, the performance of the Swedish krona had a negative impact on the Group's earnings.
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.
› Verified 2 days ago
Dr. Prashant Baliga, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Gordon Ave, Thomasville, GA 31792 Phone: 229-228-8575 | |
Keerthi Kiran Ponugoti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2705 E Pinetree Blvd Ste C, Thomasville, GA 31792 Phone: 229-584-5731 Fax: 229-584-5941 | |
William W Ellis, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Mimosa Dr, Thomasville, GA 31792 Phone: 229-551-0083 Fax: 229-227-9642 | |
Dr. Raul Gabriel Santos, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 334 Smith Ave, Thomasville, GA 31792 Phone: 229-227-1595 Fax: 229-227-1385 | |
Dr. Asif Rashid Shah, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Gordon Ave, Thomasville, GA 31792 Phone: 229-228-8575 | |
Dr. Luis Alfredo Wulff, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 W Hill St, Thomasville, GA 31792 Phone: 229-225-1900 | |
Robert D Miles Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 Mimosa Dr, Thomasville, GA 31792 Phone: 229-551-0083 Fax: 229-227-9642 |